NCT01697449已完成不适用
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (RELEVANT)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 191
- 主要终点
- Percentage of Participants With At Least One Adverse Event (AE)
研究概览
简要总结
This prospective observational study will evaluate the safety and efficacy of Avastin (bevacizumab) in patients with metastatic colorectal cancer. Data will be collected from patients receiving Avastin in combination with chemotherapy according to registered indication in routine clinical practice.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients, >/= 18 years of age
- •Metastatic colorectal cancer
- •Prescribed to receive Avastin according to registered indication
排除标准
- •Patients not eligible for Avastin treatment according to the Summary of Product Characteristics
结局指标
主要结局
Percentage of Participants With At Least One Adverse Event (AE)
时间窗: Up to 65 months
An AE was considered any unfavorable and unintended sign, symptom, or disease associated with the use of the study drug, whether or not considered related to the study drug.
次要结局
- Percentage of Participants With Clinical Benefit of Complete Response [CR], Partial Response [PR] or Stable Disease [SD] Per Response Evaluation Criteria in Solid Tumors (RECIST)(Up to 65 months)
- Percentage of Participants Who Were Resectable Postbaseline Among the Participants Who Were Unresectable at Baseline(Up to 65 months)
- Percentage of Participants With Disease Progression or Death(Up to 65 months)
- Progression Free Survival (PFS)(Up to 65 months)
研究者
相似试验
已完成
不适用
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)Colorectal CancerNCT01506167Hoffmann-La Roche719
已完成
不适用
An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)Ovarian CancerNCT01863693Hoffmann-La Roche300
已完成
不适用
An Observational Study of Avastin (Bevacizumab) and Interferon Alpha 2a in Patients With Metastatic Renal Cell Cancer (VERA)Renal Cell CancerNCT01392729Hoffmann-La Roche40
已完成
不适用
An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical PracticeNon-Squamous Non-Small Cell Lung CancerNCT01893268Hoffmann-La Roche279
撤回
3 期
A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to CetuximabColorectal CancerNCT01338558Hoffmann-La Roche